Federal Bid

Last Updated on 14 Feb 2024 at 8 PM
Solicitation
Bethesda Maryland

TURBO293 TRANSFECTION REAGENTS

Solicitation ID NOI-NIAID-24-2210343
Posted Date 14 Feb 2024 at 8 PM
Archive Date 08 Mar 2024 at 5 AM
NAICS Category
Product Service Code
Set Aside No Set-Aside Used
Contracting Office National Institutes Of Health Niaid
Agency Department Of Health And Human Services
Location Bethesda Maryland United states 20814

This is a Notice of Intent (NOI). This notice is published in accordance with Federal Acquisition Regulation (FAR) 5.101(a)(1) requiring the dissemination of information regarding proposed contract actions. This is a Notice of Intent to award a sole source, firm-fixed price purchase order under the authority of 41 U.S.C. 3304(a)(1), as implemented by FAR 13.106-1(b) - Only One Responsible Source and No Other Supplies or Service Will Satisfy Agency Requirements and is not a request for competitive quotes. 

The National Institute of Allergy and Infectious Diseases (NIAID) intends to award a firm-fixed priced, sole source, purchase order to SPEED BioSystems, LLC. 900 Clopper Road, Suite 130, Gaithersburg, MD 20878. 

TURBO293 TRANSFECTION REAGENT (20ML) QTY 45 
CAT # - PXX1002
Shipping location: 
Vaccine Research Center
BLDG 40
40 Convent Drive
Bethesda, MD 20814


The North American Industry Classification (NAICS) code for this acquisition is 325414 Biological Product (except Diagnostic) Manufacturing, with a business size standard of 1250 employees. SPEED BioSystems, LLC. is a small business.  

This will be the only notice of the Government's intent to solicit, negotiate, and award to one source to satisfy this requirement. The Government intends to award a purchase order for this requirement after the end of this notice.

While this combined synopsis/solicitation does not constitute a solicitation, interested vendors may identify their interest and capability to satisfy this requirement. The Government understands that SPEED BioSystems, LLC is the sole owner, developer, and seller of the required reagents currently being utilized by NIAID per continuity protocols and compatibility requirement. However, vendors that believe they can provide the capability required to fully meet the Government's requirement may submit a capabilities statement, including past performance, in writing to the identified point of contact prior to the closing date and time of this notice. Such documentation shall be evaluated solely for the purpose of determining whether or not to conduct this procurement on a competitive basis. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government. Interested parties may identify their interest and capability to respond to the requirement on NOI-NIAID-24-2210343 

This notice does not obligate the Government to award a purchase order or otherwise pay for any information provided in response. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization's qualifications to perform the work. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. 

For additional information or to submit responses, please contact Diana Rohlman, Contracting Specialist at [email protected]  


 

Bid Protests Not Available

Similar Past Bids

Location Unknown 14 Jun 2017 at 9 PM
Bethesda Maryland 16 Jan 2025 at 6 PM
Bethesda Maryland 11 Feb 2020 at 8 PM
Location Unknown 11 Dec 2019 at 6 PM
Location Unknown 31 May 2017 at 7 PM